Cargando…
SCHOOL Model and New Targeting Strategies
Protein-protein interactions play a central role in biological processes and thus are an appealing target for innovative drug design and development. They can be targeted by small molecule inhibitors, peptides and peptidomimetics, which represent an alternative to protein therapeutics that carry man...
Autor principal: | Sigalov, Alexander B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123132/ https://www.ncbi.nlm.nih.gov/pubmed/19065798 http://dx.doi.org/10.1007/978-0-387-09789-3_20 |
Ejemplares similares
-
Targeting Intramembrane Protein–Protein Interactions: Novel Therapeutic Strategy of Millions Years Old
por: Sigalov, Alexander B.
Publicado: (2018) -
SCHOOL of nature: ligand-independent immunomodulatory peptides
por: Sigalov, Alexander B.
Publicado: (2020) -
Commentary: Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation
por: Sigalov, Alexander B.
Publicado: (2020) -
Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles
por: Shen, Zu T., et al.
Publicado: (2015) -
SARS-CoV-2 may affect the immune response via direct inhibition of T cell receptor: Mechanistic hypothesis and rationale
por: Sigalov, Alexander B.
Publicado: (2022)